Our mission is to deliver evidence-driven, personalized therapies that combat difficult-to-treat and antimicrobial-resistant infections
Restoring hope for patients with no remaining options and broadening access to life-changing care.
To deliver evidence-driven, personalized therapies that combat difficult-to-treat and resistant infections. We strive to restore hope for patients with no remaining options and broaden access to life-changing care
Antimicrobial Resistance (AMR) : AMR is a growing global crisis, already claiming 1.3 million lives annually, a figure projected to reach 10 million by 2050. As antibiotics lose effectiveness against resistant infections, patients face life-threatening conditions with no treatment options, threatening global health and economies.
Personalized Therapy: We address difficult-to-treat and resistant infections with an innovative, evidence-driven approach to personalized phage-antibiotic therapy. By combining selective bacteriophages, advanced diagnostics, and decision-support tools, we deliver precise, effective treatments tailored to each patient. Our holistic solution restores hope for those battling difficult-to-treat and resistant bacterial infections, and expands access to transformative care.
Don’t miss any important events or news about Vésale Bioscience.
How bacteriophages offer a promising natural solution for…
read moreNamur (Belgium), 5 April 2023 Can phage therapy…
read moreNamur (Belgium), 13 January 2023 Vésale Bioscience is…
read more
